Home | Careers | Contact us 
   
   
NovaLead receives "BIRAC Innovator Award 2015"
SERVICES NEWS
Sun Pharma
enters into agreement with VLife
PRODUCTS NEWS

 
 
 
 
   Watson Pharma renews agreement with VLife
 

Watson Pharmaceuticals Inc (Now Actavis) the third largest global generics player, has renewed contract of undiclosed value with VLife through its Indian subsidiary, in the area of genotoxicity predictions of compounds of Watson's interest to be delivered using VLife's proprietary technology platform.

VLife has been providing genotoxicity pediction services to several generic companies around the world. The renew of contract with Watson is a major step in establishing VLife's strengths in the area of genotoxicity prediction, analysis and justification.

About Watson:
Watson Pharma is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. Watson Global and U.S. headquarters are in Parsippany, New Jersey, USA, and international headquarters in Zug, Switzerland. Watson Pharma is world’s third-largest generic pharmaceutical company, with more than 750 molecules in 1,700 dosage combinations marketed globally through operations in approximately 60 countries. Watson Pharma India Pvt. Ltd., headquartered in Mumbai, is the Indian arm of global Watson Pharma.

About VLife:
VLife Sciences Technologies Private Limited, Pune is a leading provider of licensed software and research solutions for research projects in a variety of sectors including genotoxicity predictions . The software offers numerous unique and specialized features for applications in computer aided molecular discovery, bioinformatics, biotechnology and chemoinformatics. Technologies developed by VLife are unique, novel and offer advantages in terms of speed and accuracy thus leading to improved outcome from research projects. VLife offers the VLifeMDS® suite for a comprehensive approach to computer aided drug design and the QSARpro® suite for advanced quantitative structure activity relationships analysis leading to new molecule design.
VLife's ViTAL® for predicting genotoxic potential of impurities and degradation products associated with drug substance or API.

For more details please visit: www.vlifesciences.com or contact us at info@vlifesciences.com


 
PRODUCT SUITES
VLifeMDS
QSARpro
BioPredicta
ChemXplor
FUNCTIONAL PRODUCTS
VLifeBase
VLife Engine
ProModel
VLifeDock
VLifeQSAR
MolSign
LeadGrow
ChemDBS
ProViz
RESEARCH SERVICES
NCE discovery & optimization
New Indication discovery
Exploring shelf
Go - no go decision support
KNOWLEDGE SERVICES
Virtual screening
Protein modeling & docking
QSAR modeling
Activity/ Tox/ ADME prediction
TECHNOLOGY SERVICES
Custom development
Research automation
Idea -> Algorithm -> Software
Database management
 
Sitemap Glossary Legal Notice
© Copyrights 2014, NovaLead Pharma. All Rights Reserved